IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma
収録刊行物
-
- Blood
-
Blood 90 2188-2195, 1997
Blood 90 2188-2195, 1997